drugset / Trial / NCT01514812

A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects

NCT01514812 ↗

Phase 1 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverQuadruple-blind

Summary

This study is to evaluate the effect of YM150 on the plasma concentration of digoxin in healthy subjects.

Timeline

Start
2006-02
Primary completion
2006-04
Completion
2006-04

Outcome

Met primary endpoint

paper The 90 % CI for the GMRs fell within the limits of 0.80-1.25, indicating a lack of drug-drug interaction. PMID 23754514 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.25 mg —
Subject darexaban Small molecule 120 mg Oral

Indications

No indication recorded.